AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients

Endocrine resistance is a significant problem in breast cancer treatment. Thus identification and validation of novel resistance determinants is important to improve treatment efficacy and patient outcome. In our work, AGR2 expression was determined by qRT-PCR in Tru-Cut needle biopsies from tamoxif...

Descripción completa

Detalles Bibliográficos
Autores principales: Hrstka, Roman, Brychtova, Veronika, Fabian, Pavel, Vojtesek, Borivoj, Svoboda, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776368/
https://www.ncbi.nlm.nih.gov/pubmed/24167368
http://dx.doi.org/10.1155/2013/761537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776368/
https://www.ncbi.nlm.nih.gov/pubmed/24167368
http://dx.doi.org/10.1155/2013/761537

Ejemplares similares